Cargando…

Enhancing Immunogenicity of Influenza Vaccine in the Elderly through Intradermal Vaccination: A Literature Analysis

Background: Aging and immunosenescence lead to a gradual decline in immune responses in the elderly and the immunogenicity of influenza vaccines in this age group is sub-optimal. Several approaches have been explored to enhance the immunogenicity of influenza vaccines in the elderly, including incor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Quach, Huy Quang, Kennedy, Richard B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9698533/ https://www.ncbi.nlm.nih.gov/pubmed/36366536 http://dx.doi.org/10.3390/v14112438

Ejemplares similares

A Meta‐analysis of intradermal versus intramuscular influenza vaccines: Immunogenicity and Adverse Events
por: Marra, Fawziah, et al.
Publicado: (2012)

Evaluating immunogenicity of pathogen-derived T-cell epitopes to design a peptide-based smallpox vaccine
por: Quach, Huy Quang, et al.
Publicado: (2022)

Immunogenicity and safety of intradermal influenza vaccine in immunocompromized patients: a meta-analysis of randomized controlled trials
por: Pileggi, Claudia, et al.
Publicado: (2015)

The Immunogenicity of Fractional Intradermal Doses of the Inactivated Poliovirus Vaccine Is Associated With the Size of the Intradermal Fluid Bleb
por: Bibby, Jack, et al.
Publicado: (2017)

1054 Immunogenicity And Safety of Quadrivalent Influenza Vaccine Administered Intradermally (ID) in Adults 18 through 64 Years of Age
por: Gorse, Geoffrey J., et al.
Publicado: (2014)

Immunogenicity and Safety of Reduced-Dose Intradermal vs Intramuscular Influenza Vaccines: A Systematic Review and Meta-analysis
por: Egunsola, Oluwaseun, et al.
Publicado: (2021)

Immunogenicity and reactogenicity of accelerated regimens of fractional intradermal COVID-19 vaccinations
por: Niyomnaitham, Suvimol, et al.
Publicado: (2023)

A novel intradermal tattoo-based injection device enhances the immunogenicity of plasmid DNA vaccines
por: Gomez, Alejandro M., et al.
Publicado: (2022)

Long-term immunogenicity of the influenza vaccine at reduced intradermal and full intramuscular doses among healthy young adults
por: Song, Joon Young, et al.
Publicado: (2013)

Safety and tolerability of intradermal influenza vaccination in patients with cardiovascular disease
por: Phrommintikul, Arintaya, et al.
Publicado: (2014)

T Cell Transcriptional Signatures of Influenza A/H3N2 Antibody Response to High Dose Influenza and Adjuvanted Influenza Vaccine in Older Adults
por: Haralambieva, Iana H., et al.
Publicado: (2022)

Intradermal vaccination of live attenuated influenza vaccine protects mice against homologous and heterologous influenza challenges
por: Lee, Andrew Chak-Yiu, et al.
Publicado: (2021)

Nanoparticles in influenza subunit vaccine development: Immunogenicity enhancement
por: Khalaj‐Hedayati, Atin, et al.
Publicado: (2019)

Immunogenicity of a protective intradermal DNA vaccine against lassa virus in cynomolgus macaques
por: Jiang, Jingjing, et al.
Publicado: (2019)

Alternative Methods of Vaccine Delivery: An Overview of Edible and Intradermal Vaccines
por: Criscuolo, E., et al.
Publicado: (2019)

Intradermal influenza vaccination in complete remission cancer patients: molecular insights
por: Bedognetti, Davide, et al.
Publicado: (2013)

Rapid safety assessment of a seasonal intradermal trivalent influenza vaccine
por: Demeulemeester, Marc, et al.
Publicado: (2016)

Delivery Systems for Intradermal Vaccination
por: Kim, Y. C., et al.
Publicado: (2011)

Emerging adjuvants for intradermal vaccination
por: Chen, Xinyuan
Publicado: (2023)

Current evidence on intradermal influenza vaccines administered by Soluvia™ licensed micro injection system
por: Icardi, Giancarlo, et al.
Publicado: (2012)

Virus-specific and shared gene expression signatures in immune cells after vaccination in response to influenza and vaccinia stimulation
por: Quach, Huy Quang, et al.
Publicado: (2023)

The adjuvant GLA-AF enhances human intradermal vaccine responses
por: Carter, Darrick, et al.
Publicado: (2018)

Intradermal influenza vaccination of healthy adults using a new microinjection system: a 3-year randomised controlled safety and immunogenicity trial
por: Beran, Jiri, et al.
Publicado: (2009)

Analysis of R848 as an Adjuvant to Improve Inactivated Influenza Vaccine Immunogenicity in Elderly Nonhuman Primates
por: Crofts, Kali F., et al.
Publicado: (2022)

Welfare Benefits of Intradermal Vaccination of Piglets
por: Temple, Déborah, et al.
Publicado: (2020)

Evaluation of the Safety and Immunogenicity of Fractional Intradermal COVID-19 Vaccines as a Booster: A Pilot Study
por: Niyomnaitham, Suvimol, et al.
Publicado: (2022)

Changes in Human Langerhans Cells Following Intradermal Injection of Influenza Virus-Like Particle Vaccines
por: Pearton, Marc, et al.
Publicado: (2010)

Safety and immunogenicity of investigational seasonal influenza hemagglutinin DNA vaccine followed by trivalent inactivated vaccine administered intradermally or intramuscularly in healthy adults: An open-label randomized phase 1 clinical trial
por: Carter, Cristina, et al.
Publicado: (2019)

Performance of LBSap Vaccine after Intradermal Challenge with L. infantum and Saliva of Lu. longipalpis: Immunogenicity and Parasitological Evaluation
por: Roatt, Bruno Mendes, et al.
Publicado: (2012)

Needle adapters for intradermal administration of fractional dose of inactivated poliovirus vaccine: Evaluation of immunogenicity and programmatic feasibility in Pakistan
por: Saleem, Ali Faisal, et al.
Publicado: (2017)

Comparing the safety and immunogenicity of a candidate TB vaccine MVA85A administered by intramuscular and intradermal delivery()
por: Meyer, Joel, et al.
Publicado: (2013)

Seroprevalence of Measles Antibodies in a Highly MMR-Vaccinated Population
por: Quach, Huy Quang, et al.
Publicado: (2022)

Dissolving Microneedles for Intradermal Vaccination against Shigellosis
por: Pastor, Yadira, et al.
Publicado: (2019)

Does an Intradermal Vaccination for Monkeypox Make Sense?
por: Mrsny, Randall J.
Publicado: (2022)

Correction: Changes in Human Langerhans Cells Following Intradermal Injection of Influenza Virus-Like Particle Vaccines
por: Pearton, Marc, et al.
Publicado: (2010)

Effects of Prior Influenza Exposure on Immunogenicity of Influenza Vaccine
por: Cao, Jia-Qian, et al.
Publicado: (2020)

Safety and immunogenicity of an MF59™-adjuvanted subunit influenza vaccine in elderly Chinese subjects
por: Li, Rongcheng, et al.
Publicado: (2008)

Feasibility of conducting intradermal vaccination campaign with inactivated poliovirus vaccine using Tropis intradermal needle free injection system, Karachi, Pakistan
por: Yousafzai, Mohammad Tahir, et al.
Publicado: (2017)

Comparative immunogenicity analysis of intradermal versus intramuscular immunization with a recombinant human adenovirus type 5 vaccine against Ebola virus
por: Zhang, Zhe, et al.
Publicado: (2022)

Nine μg intradermal influenza vaccine and 15 μg intramuscular influenza vaccine induce similar cellular and humoral immune responses in adults
por: Nougarede, Nolwenn, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_fccst2gbh03b65bge1vteohq72